Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TDRD3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | SDCBP | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | TRIM65 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | DHX30 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | FANCA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | HECA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | DDX39A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | TOMM22 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | SLC25A16 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | MLPH | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |